683 Capital Management’s Ventyx Biosciences VTYX Stock Holding History

683 Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,040,000	Closed	-$9.39M	–	267
2025 Q4	$9.39M	Buy	1,040,000 +40,000	+4%	+$299K	0.41%	51
2025 Q3	$3.11M	Buy	+1,000,000	New	+$2.65M	0.16%	94
2024 Q1	–	Sell	-120,000	Closed	-$296K	–	263
2023 Q4	$296K	Buy	+120,000	New	+$1.14M	0.02%	120

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

683 Capital Management's VTYX Position: Q1 2026 in Review

683 Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 1,040,000 shares — an estimated $9.39M sold.

683 Capital Management first reported a position in VTYX in Q4 2023 and held it in 3 quarters. The position peaked at $9.39M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

683 Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
683 Capital Management sold 1,040,000 Ventyx Biosciences shares in Q1 2026, an estimated $9.39M.
683 Capital Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 3 quarters.
683 Capital Management's Ventyx Biosciences position peaked at $9.39M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.